We are live on !
Find out more
Penbrook Management Portfolio holdings
AUM
$169M
Turnover
8.49%
1-Year Est. Return
32.52%
This Fund
S&P 500
This Quarter Est. Return
+1.85%
1 Year Est. Return
+32.52%
3 Year Est. Return
+106.62%
5 Year Est. Return
+155.24%
10 Year Est. Return
–
AUM
$169M
AUM Growth
+$12.7M
(+8.1%)
Cap. Flow
+$992K
Cap. Flow % of AUM
Cap. Flow %
0.59%
Top 10 Holdings %
Top 10 Hldgs %
50.36%
Holding
106
New
5
Increased
12
Reduced
34
Closed
4
Avg Time Held
5.8
years
Top 10 Avg Time Held
5.3
years
Top 20 Avg Time Held
4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sky Harbour Group
SKYH
|
+$1.84M |
| 2 |
Allot
ALLT
|
+$814K |
| 3 |
Electrovaya
ELVA
|
+$414K |
| 4 |
Cenovus Energy
CVE
|
+$387K |
| 5 |
TETRA Technologies
TTI
|
+$335K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DoubleVerify
DV
|
+$1.11M |
| 2 |
CuriosityStream
CURI
|
+$1.04M |
| 3 |
Antero Midstream
AM
|
+$225K |
| 4 |
Novo Nordisk
NVO
|
+$217K |
| 5 |
First American
FAF
|
+$206K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.07% |
| 2 | Energy | 19.64% |
| 3 | Healthcare | 13.97% |
| 4 | Communication Services | 13.15% |
| 5 | Consumer Discretionary | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Novartis
NVS
$297B
| $790K | 0.47% |
5,540
| – | – |
2013 Q4
51 quarters
|
|
52
NPK International
NPKI
$909M
| $769K | 0.45% |
67,325
-500
| -0.7% | -$6.71K |
2023 Q4
11 quarters
|
|
53
Backblaze
BLZE
$553M
| $726K | 0.43% |
51,900
-1,800
| -3% | -$27K |
2024 Q4
7 quarters
|
|
54
Western Midstream Partners
WES
$18.3B
| $705K | 0.42% |
15,900
| – | – |
2024 Q4
7 quarters
|
|
55
Invesco QQQ Trust
QQQ
$479B
| $684K | 0.4% |
925
| – | – |
2018 Q3
32 quarters
|
|
56
abrdn Physical Gold Shares ETF
SGOL
$6.76B
| $676K | 0.4% |
17,080
| – | – |
2025 Q1
6 quarters
|
|
57
Kulicke & Soffa
KLIC
$3.91B
| $669K | 0.39% |
7,100
| – | – |
2021 Q4
19 quarters
|
|
58
Amplitude
AMPL
$2.11B
| $664K | 0.39% |
47,955
-750
| -2% | -$8.66K |
2026 Q2
1 quarter
|
|
59
Asure Software
ASUR
$211M
| $664K | 0.39% |
87,705
-430
| -0.5% | -$3.59K |
2023 Q4
11 quarters
|
|
60
Iovance Biotherapeutics
IOVA
$6.37B
| $611K | 0.36% |
41,195
-20,750
| -33% | -$148K |
2025 Q4
3 quarters
|
|
61
First Bancorp
FBP
$4.19B
| $595K | 0.35% |
22,600
| – | – |
2013 Q4
51 quarters
|
|
62
Regeneron Pharmaceuticals
REGN
$84.6B
| $595K | 0.35% |
785
| – | – |
2021 Q1
22 quarters
|
|
63
Paysign
PAYS
$850M
| $531K | 0.31% |
39,420
-17,890
| -31% | -$203K |
2025 Q4
3 quarters
|
|
64
Range Resources
RRC
$10B
| $522K | 0.31% |
14,090
-150
| -1% | -$5.89K |
2022 Q4
15 quarters
|
|
65
Aehr Test Systems
AEHR
$1.86B
| $518K | 0.31% |
5,200
| – | – |
2024 Q2
9 quarters
|
|
66
Apple
AAPL
$5.04T
| $509K | 0.3% |
1,529
| – | – |
2013 Q4
51 quarters
|
|
67
Hercules Capital
HTGC
$3.09B
| $501K | 0.3% |
29,786
+399
| +1% | +$6.7K |
2023 Q1
14 quarters
|
|
68
Power Integrations
POWI
$2.65B
| $477K | 0.28% |
9,200
| – | – |
2013 Q4
51 quarters
|
|
69
Franklin Master Intermediate Income Trust
PIM
$144M
| $459K | 0.27% |
152,063
+5,000
| +3% | +$15.7K |
2013 Q4
51 quarters
|
|
70
Dorchester Minerals
DMLP
$1.46B
| $455K | 0.27% |
16,225
| – | – |
2022 Q2
17 quarters
|
|
71
iShares 20+ Year Treasury Bond ETF
TLT
$48.9B
| $419K | 0.25% |
5,385
-125
| -2% | -$10.3K |
2026 Q2
1 quarter
|
|
72
Bristol-Myers Squibb
BMY
$128B
| $413K | 0.24% |
6,615
| – | – |
2025 Q4
3 quarters
|
|
|
73
TETRA Technologies
TTI
$745M
| $409K | 0.24% |
69,760
+43,500
| +166% | +$335K |
2025 Q3
4 quarters
|
|
74
Enterprise Products Partners
EPD
$78.4B
| $407K | 0.24% |
11,427
| – | – |
2024 Q3
8 quarters
|
|
75
Kopin
KOPN
$610M
| $382K | 0.23% |
82,975
-5,300
| -6% | -$23K |
2024 Q4
7 quarters
|
|
Similar funds
Penbrook Management's Q3 2026 Portfolio in Review
As of Q3 2026, Penbrook Management held 106 positions worth $169M, up 8.1% from $157M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Penbrook Management's Q3 2026 filing shows 5 new, 12 increased, 34 reduced and 4 closed positions. Its largest new stake was Lockheed Martin: 550 shares worth $280K. The largest sale was DoubleVerify, an estimated $1.11M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Energy and Healthcare.
- Penbrook Management's largest Q3 2026 buy was Lockheed Martin: 550 shares worth $280K.
- Penbrook Management added most to Sky Harbour Group in Q3 2026, an estimated $1.84M increase.
- Penbrook Management's biggest Q3 2026 reduction was CuriosityStream, cutting an estimated $1.04M.
- Penbrook Management fully exited DoubleVerify in Q3 2026, selling an estimated $1.11M.
- Penbrook Management's ten largest holdings make up 50% of its $169M portfolio in Q3 2026.
- Penbrook Management opened 5 new positions and closed 4 in Q3 2026.
- Penbrook Management's portfolio value rose 8.1% quarter-over-quarter to $169M.
Based on Penbrook Management's 13F filing for Q3 2026, filed 16 Oct 2026.